TCL Archive Neutron Therapy “Treatment Of Choice” In Salivary Gland Tumors – 100 Percent Complete Reponses June 13, 1986
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive Stereotactic Radiosurgery Improves Survival Without Whole-Brain Radiotherapy September 27, 2013